Hyderabad-based corporates — Bharat Biotech, Granules and Suven Life Sciences — have bagged awards for 2011-12 from the Pharmaceuticals Export Promotion Council of India (Pharmexil) .
The winners were presented with the awards at the recent India-Asia-Pacific pharma business meet and annual general body meeting of the council.
Bharat Biotech won the silver patent award in recognition of its contributions in biotech products and research.
The company has filed several novel patents.
Krishna Ella, Chairman and Managing Director, said the award recognises the innovation at Bharat Biotech, and the credit goes to the researchers who have worked hard to make it happen.
Suven Life Sciences Ltd received the platinum patent award for securing the most number of product and process patents for the fourth year in a row.
The company secured 96 product patents for their New Chemical Entities and 9 process patents during 2011-12 from several countries including US, Europe, Japan, Australia and Canada. So far, the company has got a total of 541 product patents globally, said Venkat Jasti, CEO.
In another development, Granules India Ltd has been recognised as India’s most-admired company in exports & bulk drugs at the 5th Annual Pharmaceutical Business Leadership Awards, organised by Pharmaleaders, in association with BSE, Pharmexcil and IBEF.
Due to the strong performance of our Finished Dosage Division, we expect our export business to continue to increase,” said Harsha, Executive Director, Granules India Ltd, after receiving the awards from the Maharastra Governor, K. Sankaranarayanan, recently.